Thynk Capital Investor
Thynk Capital, founded by Jim Plante, is focused on early-stage Therapeutics, Healthcare and Technology companies. The investment strategy has a strong focus in opportunities that have the potential of becoming an innovative break thru, a modern replacement or a complement to existing products on the market.
Invests into
Industry:
Biotechnology
Headquarters:
United States
Founded Date:
2011
Employees Number:
1-10
Investor Type:
Historical Investment Performance in Top 1% of Venture Funds. Primary focus on Longevity and defeating Diseases of Aging.
Number Of Exits:
15
Register and Claim Ownership